Evidence map›Paper›PMID 25531426›Full record

ArticleAnalytical chemistry2015

Development of a nanobody-alkaline phosphatase fusion protein and its application in a highly sensitive direct competitive fluorescence enzyme immunoassay for detection of ochratoxin A in cereal.

Xing Liu, Yang Xu, De-bin Wan, Yong-hua Xiong, Zhen-yun He, Xian-xian Wang, Shirley J Gee, Dojin Ryu, Bruce D Hammock

Abstract readValidation Study
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recombinant antibodies and their use for food immunoanalysis.Analytical and bioanalytical chemistry · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xing LiuState Key Laboratory of Food Science and Technology and ‡Sino-Germany Joint Research Institute, Nanchang University , No. 235 Nanjing East Road, Nanchang 330047, People's Republic of China.
Yang Xu
De-bin Wan
Yong-hua Xiong
Zhen-yun He
Xian-xian Wang
Shirley J Gee
Dojin Ryu
Bruce D Hammock

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
The Western Center for Agricultural Health and Safety at UC DavisU50OH007550 · OH · UNIVERSITY OF CALIFORNIA DAVIS · PI SCHENKER, MARC B · 2001 to 2010
$5.4M
NIEHS NIH HHS P42 ES004699NIEHS NIH HHS P42ES04699NIOSH CDC HHS 2U50OH007550NIOSH CDC HHS U50 OH007550
6 · The paper itself

Abstract

A rapid and sensitive direct competitive fluorescence enzyme immunoassay (dc-FEIA) for ochratoxin A (OTA) based on a nanobody (Nb)-alkaline phosphatase (AP) fusion protein was developed. The VHH (variable domain of heavy chain antibody) gene of Nb28 was subcloned into the expression vector pecan45 containing the AP double-mutant gene. The Nb28-AP construct was transformed into Escherichia coli BL21(DE3)plysS, and soluble expression in bacteria was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot. Both the Nb properties and AP enzymatic activity were validated by colorimetric and fluorometric analysis. The 50% inhibitory concentration and the detection limit of the dc-FEIA were 0.13 and 0.04 ng/mL, respectively, with a linear range of 0.06-0.43 ng/mL. This assay was compared with LC-MS/MS, and the results indicated the reliability of Nb-AP fusion protein-based dc-FEIA for monitoring OTA contamination in cereal.

Indexed as

Alkaline PhosphataseEdible GrainEscherichia coliFluorometryImmunoenzyme TechniquesLimit of DetectionMycotoxinsOchratoxinsRecombinant Fusion ProteinsSingle-Domain AntibodiesAlkaline PhosphataseMycotoxinsochratoxin AOchratoxinsRecombinant Fusion ProteinsSingle-Domain Antibodies

Identifiers

PMID25531426
PMCPMC4476795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.